GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ULTA · Aug 2, 2025

Ulta Beauty, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001558370-25-011804General Corporate
Capex intensity35thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

2.76% · OPTIONAL · VALID

Operating cash generation25thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

3.46% · OPTIONAL · VALID

Revenue growth45thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

9.26% · CORE · VALID

Gross margin45thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

39.15% · CORE · VALID

Operating margin15thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

12.37% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History62 statesSelf-history eligible
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
2.77%
Current
2.76%
Delta
-0.01%
Cash Generation Decreased
Previous
7.72%
Current
3.46%
Delta
-4.26%
Growth Increased
Previous
4.49%
Current
9.26%
Delta
4.77%
Margin Increased
Previous
39.12%
Current
39.15%
Delta
0.03%
Profitability Decreased
Previous
14.11%
Current
12.37%
Delta
-1.74%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.